Efficacy of Transcutaneous Electrical  Nerve Stimulation in the Treatment of  Overactive Bladder

Sharma, Nidhi; Rekha, K. Sashi; Srinivasan, Krishnamurthy Jayashree

doi:10.7860/jcdr/2016/21683.8729

Cited by 7 publications

(6 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, urinary frequency, episodes of urgency, and urge incontinence were reduced with TENS applied over S3. 25 Data presented in this study seem to support the neuromodulation mechanism describe previously.…”

Section: Discussionsupporting

confidence: 91%

See 1 more Smart Citation

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Management of Neurogenic Overactive Bladder

Liu

Xú²,

Geng³

2021

Am J Phys Med Rehabil

View full text Add to dashboard Cite

The aim of the study was to investigate the therapeutic effect of transcutaneous electrical nerve stimulation on neurogenic overactive bladder that is refractory to pharmacotherapy. Methods: This randomized trial recruited 83 participants with neurogenic overactive bladder that were nonresponsive to 3-mo first-line anticholinergic drug treatment. Participants were randomized into treatment and control groups. Transcutaneous electrical nerve stimulation current consisting of biphasic square wave with pulse durations of 150 μs and pulse frequency set at 20 Hz were applied to for 30 mins once a day for 90 days. Stimulation was provided over the lateral aspect of the sacrum bilaterally of the electrodes. Patients in the transcutaneous electrical nerve stimulation group stopped taking the anticholinergic drugs. The control group continued to receive anticholinergic drugs for 90 days. The participants' Overactive Bladder Symptom Score, the Medical Outcomes Study 36-Item Short-Form Health Survey scores, urodynamic values, and voiding diary data were assessed before and after the therapy. Results: The transcutaneous electrical nerve stimulation treatment group had significantly decreased Overactive Bladder Symptom scores compared with the control group (P < 0.001); in addition, half of the Medical Outcomes Study 36-Item Short-Form Health Survey scores were significantly improved in the transcutaneous electrical nerve stimulation group (P < 0.05). The patients treated with transcutaneous electrical nerve stimulation improved significantly voiding diary parameters at P < 0.05. Similarly, urodynamic values at P < 0.05 favored the experimental group over the control group. Conclusions: Applying daily transcutaneous electrical nerve stimulation over the sacral region for 90 days to patient with neurogenic overactive bladder improved overactive bladder symptoms of patients whose response to anticholinergic drugs is far inferior.

show abstract

Section: Discussionsupporting

confidence: 91%

“…Cystometric capacity was significantly greater with TENS on S3 than with the other electrode configurations. In addition, urinary frequency, episodes of urgency, and urge incontinence were reduced with TENS applied over S3 25 . Data presented in this study seem to support the neuromodulation mechanism describe previously.…”

Section: Discussionsupporting

confidence: 90%

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Management of Neurogenic Overactive Bladder

Liu

Xú²,

Geng³

2021

Am J Phys Med Rehabil

View full text Add to dashboard Cite

show abstract

“…Indications Pregnancy, childbirth, age, long-term increase in abdominal pressure, menopause, obesity and other causes of muscle, connective tissue, fascia and other abnormalities or injuries, which in turn induce a series of conventional pelvic floor dysfunction, such as lower urinary symptoms, pelvic organ prolapse, defecation disorders, chronic pelvic pain, sexual dysfunction; pelvic floor dysfunction of non-surgical indications [29]; post-pelvic surgery urinary / defecation disorders, postpartum pelvic floor dysfunction of prevention and treatment. [30][31][32][33][34][35] Active infection at the site of irritation; bladder stones; pregnant women; pelvic tumors; menstruation, puerperium; neurological or mental diseases; cardiac pacemakers. Neurological diseases; cardiac pacemakers; cognitive disorders; genitourinary inflammation in the acute stage.…”

Section: Principles and Contents Of Treatment For Pelvic Floor Dysfun...mentioning

confidence: 99%

The Process of Diagnosis and Treatment of Female Pelvic Floor Dysfunction and the Clinical Application of Physical Therapy

Wei,

Zheng,

Liu

et al. 2023

Preprint

View full text Add to dashboard Cite

Female pelvic floor dysfunction (FPFD) is a series of conditions caused by the displacement or dysfunction of the patient's pelvic organs due to defects, injuries, and deterioration of the pelvic floor supportive structures, with stress urinary incontinence and pelvic organ prolapse being the most common. The mechanism of pelvic floor dysfunction is complex and not yet fully understood, and is often related to one or more functional abnormalities of muscles, connective tissues, fascia, nerves and blood vessels. Specialized clinicians are often unable to cover the comprehensive medical professional information of various specialties such as gynecology and obstetrics, urology, anus and intestines, imaging, etc., and the systematic and comprehensive diagnosis and treatment of the disease will be limited. The application of artificial intelligence concepts in the medical field not only improves the diagnostic efficiency of physicians, but also provides reference and basis for the development of comprehensive treatment programs. This article follows and draws on the diagnosis and treatment process of pelvic floor dysfunction recommended in various guidelines, incorporates physical therapy techniques into the conventional non-surgical treatment of pelvic floor dysfunction, provides guidance for the diagnosis and treatment of pelvic floor dysfunction, and briefly introduces the clinical application and value of pelvic floor intelligent diagnosis and treatment in pelvic floor dysfunction.

show abstract

“…19,20 Urge and voiding frequency, number of nocturia, frequency of incontinence, and OAB scores were used to evaluate effectiveness in related studies. [19][20][21] Also, more than 50% reduction in urge incontinence episodes was accepted as the complete response in studies. 3,22,23 Although this is a subjective classification, the authors…”

Section: Inclusion Criteria Exclusion Criteriamentioning

confidence: 99%

Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial

et al. 2021

View full text Add to dashboard Cite

Objectives Transcutaneous tibial nerve stimulation (TTNS) is a noninvasive method used in OAB treatment. Purpose of this study is to compare the effectiveness of the TTNS procedure applied once a week and three times a week in women diagnosed with wet type refractory OAB. Methods A total of 60 patients diagnosed with wet type OAB that was refractory to medical treatment were included in the study. Participants were equally and randomly divided into two groups: TTNS treatment was performed with a duration of 30 minutes for 12 weeks, once a week to Group I and three times a week to Group II. Pretreatment and posttreatment OAB‐V8/ICIQ‐SF scores and voiding frequencies recorded in the bladder diary were compared between groups. Results Four patients in Group 1 and eight in Group 2 left the study without completing the treatment. TTNS was performed in both groups for 12 weeks. There was a significant decrease in the voiding frequency, OAB‐V8, ICIQ‐SF scores in both group 1 and group 2 (P < .001). A significant decrease in the OAB‐V8 score was observed in the 5th week in Group 1, and in the 3rd week in Group 2. Complete response was observed in 6 patients (23.1%) in Group 1 after 12 weeks of TTNS procedure. In Group 2, 10 patients (45.5%) had a complete response. After the 12‐week TTNS procedure, no significant difference was observed between the groups in terms of treatment response. Conclusion TTNS can be safely used before invasive treatments in resistant OAB. TTNS procedure three times a week seems more effective than performing it once a week.

show abstract

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Treatment of Overactive Bladder

Abstract: In elderly women, patients with OAB where other co-medications have their own anticholinergic side effects and impairment of cognition is a concern, TENS can be a useful intervention. TENS units are safe, economical and easily commercially available.

Cited by 7 publications

References 17 publications

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Management of Neurogenic Overactive Bladder

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Management of Neurogenic Overactive Bladder

The Process of Diagnosis and Treatment of Female Pelvic Floor Dysfunction and the Clinical Application of Physical Therapy

Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial

Contact Info

Product

Resources

About